<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 03, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00005531</url>
  </required_header>
  <id_info>
    <org_study_id>5064</org_study_id>
    <secondary_id>R01HL054306</secondary_id>
    <nct_id>NCT00005531</nct_id>
  </id_info>
  <brief_title>Genetic Epidemiology of Sarcoidosis</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Heart, Lung, and Blood Institute (NHLBI)</source>
  <brief_summary>
    <textblock>
      To determine if hereditary susceptibility predisposes African Americans to sarcoidosis and to&#xD;
      identify sarcoidosis susceptibility genes in African Americans.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND:&#xD;
&#xD;
      Sarcoidosis is a multisystem, granulomatous inflammatory disease of unknown etiology.&#xD;
      Hereditary susceptibility to sarcoidosis is suggested by reports of familial clustering and a&#xD;
      higher prevalence in certain ethnic groups, particularly African-Americans. Over four hundred&#xD;
      kindreds been reported in the medical literature and these investigators have recently&#xD;
      described 101 families and shown that African Americans have a higher prevalence rate of&#xD;
      familial sarcoidosis than Caucasians (19 percent vs. 5 percent). The reasons why sarcoidosis&#xD;
      clusters in families or the role of genetic factors in this disease are not known.&#xD;
&#xD;
      DESIGN NARRATIVE:&#xD;
&#xD;
      The study was carried out in African American families ascertained through 400 African&#xD;
      American sarcoidosis patients evaluated at the Henry Ford Health System. They were tested for&#xD;
      association of sarcoidosis with markers for candidate genes using the affected family-based&#xD;
      control method and tested for possible environmental risk factors and genetic mechanisms of&#xD;
      disease transmission by performing a segregation analysis in African American families.&#xD;
&#xD;
      A strong association of one or more of the candidate genes with sarcoidosis or an indication&#xD;
      of major gene segregation for the disease, provided the basis for future linkage studies.&#xD;
      Investigating the hereditary susceptibility of sarcoidosis was best done in African&#xD;
      Americans, because of the greater severity and occurrence of disease in this population. Once&#xD;
      the reasons for familial aggregation of sarcoidosis are determined, the etiology of this&#xD;
      disease will be better understood and it should be possible to design new approaches to&#xD;
      prevention and treatment.&#xD;
&#xD;
      The study completion date listed in this record was obtained from the &quot;End Date&quot; entered in&#xD;
      the Protocol Registration and Results System (PRS) recor&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 1996</start_date>
  <completion_date type="Actual">November 2000</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <condition>Lung Diseases</condition>
  <condition>Sarcoidosis</condition>
  <eligibility>
    <criteria>
      <textblock>
        No eligibility criteria&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Iannuzzi</last_name>
    <affiliation>Case Western Reserve University</affiliation>
  </overall_official>
  <reference>
    <citation>Rybicki BA, Maliarik MJ, Bock CH, Elston RC, Baughman RP, Kimani AP, Sheffer RG, Chen KM, Major M, Popovich J Jr, Iannuzzi MC. The Blau syndrome gene is not a major risk factor for sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 1999 Sep;16(2):203-8.</citation>
    <PMID>10560124</PMID>
  </reference>
  <reference>
    <citation>Rybicki BA, Maliarik MJ, Malvitz E, Sheffer RG, Major M, Popovich J Jr, Iannuzzi MC. The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans. Hum Immunol. 1999 Sep;60(9):867-74. doi: 10.1016/s0198-8859(99)00050-6.</citation>
    <PMID>10527395</PMID>
  </reference>
  <reference>
    <citation>Maliarik MJ, Rybicki BA, Malvitz E, Sheffer RG, Major M, Popovich J Jr, Iannuzzi MC. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med. 1998 Nov;158(5 Pt 1):1566-70. doi: 10.1164/ajrccm.158.5.9804123.</citation>
    <PMID>9817709</PMID>
  </reference>
  <reference>
    <citation>Maliarik MJ, Chen KM, Sheffer RG, Rybicki BA, Major ML, Popovich J Jr, Iannuzzi MC. The natural resistance-associated macrophage protein gene in African Americans with sarcoidosis. Am J Respir Cell Mol Biol. 2000 Jun;22(6):672-5. doi: 10.1165/ajrcmb.22.6.3745.</citation>
    <PMID>10837363</PMID>
  </reference>
  <reference>
    <citation>Rybicki BA, Kirkey KL, Major M, Maliarik MJ, Popovich J Jr, Chase GA, Iannuzzi MC. Familial risk ratio of sarcoidosis in African-American sibs and parents. Am J Epidemiol. 2001 Jan 15;153(2):188-93. doi: 10.1093/aje/153.2.188.</citation>
    <PMID>11159165</PMID>
  </reference>
  <reference>
    <citation>Rybicki BA, Elston RC. The relationship between the sibling recurrence-risk ratio and genotype relative risk. Am J Hum Genet. 2000 Feb;66(2):593-604. doi: 10.1086/302778. Erratum In: Am J Hum Genet 2000 Aug;67(2):541.</citation>
    <PMID>10677319</PMID>
  </reference>
  <reference>
    <citation>Rybicki BA, Maliarik MJ, Poisson LM, Sheffer R, Chen KM, Major M, Chase GA, Iannuzzi MC. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med. 2003 Feb 1;167(3):444-9. doi: 10.1164/rccm.2112060.</citation>
    <PMID>12554629</PMID>
  </reference>
  <reference>
    <citation>Rybicki BA, Iyengar SK, Harris T, Liptak R, Elston RC, Sheffer R, Chen KM, Major M, Maliarik MJ, Iannuzzi MC. The distribution of long range admixture linkage disequilibrium in an African-American population. Hum Hered. 2002;53(4):187-96. doi: 10.1159/000066193.</citation>
    <PMID>12435883</PMID>
  </reference>
  <reference>
    <citation>Kucera GP, Rybicki BA, Kirkey KL, Coon SW, Major ML, Maliarik MJ, Iannuzzi MC. Occupational risk factors for sarcoidosis in African-American siblings. Chest. 2003 May;123(5):1527-35. doi: 10.1378/chest.123.5.1527.</citation>
    <PMID>12740270</PMID>
  </reference>
  <reference>
    <citation>Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. 2003 May 1;167(9):1225-31. doi: 10.1164/rccm.200209-1097OC. Epub 2003 Feb 13.</citation>
    <PMID>12615619</PMID>
  </reference>
  <verification_date>August 2004</verification_date>
  <study_first_submitted>May 25, 2000</study_first_submitted>
  <study_first_submitted_qc>May 25, 2000</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2000</study_first_posted>
  <last_update_submitted>February 17, 2016</last_update_submitted>
  <last_update_submitted_qc>February 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2016</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Sarcoidosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

